PDSB PDS Biotechnology Corporation
Healthcare$1.10-8.33%ClosedMarket Cap: $61.4M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
17.11
P/S
0.00
EV/EBITDA
-2.18
DCF Value
$0.14
FCF Yield
-6554.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-346.0%
ROA
-135.2%
ROIC
-146.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-6.5M | $-7.3M | $— | — |
| Q4 null | $0.00 | NaN% | $-6.7M | $-7.6M | $— | — |
| FY null | $0.00 | NaN% | $-31.5M | $-34.5M | $— | — |
| Q3 null | $0.00 | NaN% | $-8.1M | $-9.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-7.6M | $-9.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-9.1M | $-8.5M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-7.4M | $-8.0M | $— | — |
| FY null | $0.00 | -Infinity% | $-36.3M | $-37.6M | $— | — |
| Q3 null | $0.00 | NaN% | $-10.2M | $-10.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-8.7M | $-8.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-10.1M | $-10.6M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-10.4M | $-10.9M | $-0.34 | — |